Literature DB >> 8774494

Development of an optimal protocol for antigen retrieval: a 'test battery' approach exemplified with reference to the staining of retinoblastoma protein (pRB) in formalin-fixed paraffin sections.

S R Shi1, R J Cote, C Yang, C Chen, H J Xu, W F Benedict, C R Taylor.   

Abstract

The retinoblastoma (RB) gene, which encodes the nuclear RB protein (pRB), is believed to be involved in cell cycle control and cell differentiation. Studies have demonstrated that loss of RB function may play a role in tumour formation and progression of a variety of human tumours, such as bladder, lung, breast, and prostate cancers. The immunohistochemical detection of pRB expression in formalin-paraffin sections of human cancer has potential advantages of convenience, economy, and compatibility with routine surgical pathology practice. In practice, however, results using pRB antibodies on routinely processed, paraffin-embedded tissue have been inconsistent. In this study, the antigen retrieval (AR) method has been applied to the immunohistochemical detection of pRB in paraffin-embedded tissues and a 'test battery' approach has been developed to identify the principal variables that result in the optimal AR protocol. This approach includes the use of buffered solutions at pH 1, 6, and 10 with three different heating conditions (temperatures 120 degrees C, 100 degrees C, and 90 degrees C). In the example described here with antibody RB-WL-1, the low pH solution with the microwave heating at 100 degrees C proved most effective. Both fresh and routinely processed formalin-paraffin tissues of normal and bladder carcinoma were used for a comparison of the pRB immunostaining. The AR method was evaluated by comparing the immunohistochemical staining result on routinely processed formalin-paraffin sections with frozen sections of the same tumour. A consistent intensity of immunohistochemical staining for pRB was achieved using the identified optimal AR protocol on formalin-paraffin sections. All slides showed positive staining of pRB in normal mesenchymal and epithelial tissues. The pattern of pRB localization and intensity of staining was similar to that obtained in frozen sections, though the intensity obtained by AR treatment on paraffin sections was slightly to moderately stronger than that obtained in frozen sections. Once the protocol was identified, it was tested using routinely processed paraffin tissue sections of 245 cases of bladder carcinoma, with consistent pRB immunostaining results. The protocol described is simple to perform and gives reproducible results for evaluation of pRB expression by immunohistochemistry.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8774494     DOI: 10.1002/(SICI)1096-9896(199607)179:3<347::AID-PATH559>3.0.CO;2-L

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  14 in total

1.  Immunohistochemistry in the evaluation of neovascularization in tumor xenografts.

Authors:  D Wang; C R Stockard; L Harkins; P Lott; C Salih; K Yuan; D Buchsbaum; A Hashim; M Zayzafoon; R W Hardy; O Hameed; W Grizzle; G P Siegal
Journal:  Biotech Histochem       Date:  2008-06       Impact factor: 1.718

2.  Selection of buffer pH by the isoelectric point of the antigen for the efficient heat-induced epitope retrieval: re-appraisal for nuclear protein pathobiology.

Authors:  Hanako Kajiya; Susumu Takekoshi; Mao Takei; Noboru Egashira; Takashi Miyakoshi; Akihito Serizawa; Akira Teramoto; Robert Y Osamura
Journal:  Histochem Cell Biol       Date:  2009-09-19       Impact factor: 4.304

3.  The impact of tissue fixatives on morphology and antibody-based protein profiling in tissues and cells.

Authors:  Linda Paavilainen; Asa Edvinsson; Anna Asplund; Sophia Hober; Caroline Kampf; Fredrik Pontén; Kenneth Wester
Journal:  J Histochem Cytochem       Date:  2009-11-09       Impact factor: 2.479

4.  Improving the Proteomic Analysis of Archival Tissue by Using Pressure-Assisted Protein Extraction: A Mechanistic Approach.

Authors:  Carol B Fowler; Timothy J O'Leary; Jeffrey T Mason
Journal:  J Proteomics Bioinform       Date:  2014-06-24

5.  Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence.

Authors:  Kyung-Hwa Lee; Ji-Shin Lee; Jong-Hee Nam; Chan Choi; Min-Cheol Lee; Chang-Soo Park; Sang-Woo Juhng; Jae-Hyuk Lee
Journal:  Langenbecks Arch Surg       Date:  2011-06-25       Impact factor: 3.445

6.  Enhanced antigen retrieval of amyloid β immunohistochemistry: re-evaluation of amyloid β pathology in Alzheimer disease and its mouse model.

Authors:  Hideaki Kai; Ryong-Woon Shin; Koichi Ogino; Hiroyuki Hatsuta; Shigeo Murayama; Tetsuyuki Kitamoto
Journal:  J Histochem Cytochem       Date:  2012-07-21       Impact factor: 2.479

7.  Optimized Protocol for Quantitative Multiple Reaction Monitoring-Based Proteomic Analysis of Formalin-Fixed, Paraffin-Embedded Tissues.

Authors:  Jacob J Kennedy; Jeffrey R Whiteaker; Regine M Schoenherr; Ping Yan; Kimberly Allison; Melissa Shipley; Melissa Lerch; Andrew N Hoofnagle; Geoffrey Stuart Baird; Amanda G Paulovich
Journal:  J Proteome Res       Date:  2016-07-27       Impact factor: 4.466

8.  Lack of death receptor 4 (DR4) expression through gene promoter methylation in gastric carcinoma.

Authors:  Kyung Hwa Lee; Sang Woo Lim; Ho Gun Kim; Dong Yi Kim; Seong Yeob Ryu; Jae Kyun Joo; Jung Chul Kim; Jae Hyuk Lee
Journal:  Langenbecks Arch Surg       Date:  2009-04-07       Impact factor: 3.445

9.  Accumulation of extracellular RGR-d in Bruch's membrane and close association with drusen at intercapillary regions.

Authors:  Harold Kochounian; Lincoln V Johnson; Henry K W Fong
Journal:  Exp Eye Res       Date:  2009-02-11       Impact factor: 3.467

10.  Modeling formalin fixation and antigen retrieval with bovine pancreatic RNase A II. Interrelationship of cross-linking, immunoreactivity, and heat treatment.

Authors:  Vladimir K Rait; Lixin Xu; Timothy J O'Leary; Jeffrey T Mason
Journal:  Lab Invest       Date:  2004-03       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.